New cardiovascular targets to prevent late onset Alzheimer disease

European Journal of Pharmacology

Volumn 763, Issue , 2015, Pages 131-134

  Claassen, Jurgen A H R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Cerebral blood flow; Cognitive impairment; Dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; BIOLOGICAL MARKER;

AGE; ALZHEIMER DISEASE; APOE EPSILON4 GENE; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BRAIN PERFUSION; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; GENE; GENETIC VARIABILITY; GENETICS; GLUCOSE HOMEOSTASIS; HEART OUTPUT; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; NEUROIMAGING; ONSET AGE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; ANIMAL; CARDIOVASCULAR DISEASES; COMPLICATION; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ALZHEIMER DISEASE; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84941935329     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.022     Document Type: Article

References (28)

1. A. Alzheimer, R.A. Stelzmann, H.N. Schnitzlein, and F.R. Murtagh An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde" Clin. Anat. 8 1995 429 431
2. G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol. 5 2006 64 74
3. J.A. Claassen Cognitive decline and dementia: are we getting to the vascular heart of the matter? Hypertension 65 2015 505 506
4. J.A. Claassen, R. Diaz-Arrastia, K. Martin-Cook, B.D. Levine, and R. Zhang Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler J. Alzheimer's Dis.: JAD 17 2009 621 629
5. J.A. Claassen, B.D. Levine, and R. Zhang Dynamic cerebral autoregulation during repeated squat-stand maneuvers J. Appl. Physiol. 106 2009 153 160
6. J.A. Claassen, and R. Zhang Cerebral autoregulation in Alzheimer's disease J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 31 2011 1572 1577
7. A.S. den Abeelen, J. Lagro, A.H. van Beek, and J.A. Claassen Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease Curr. Alzheimer Res. 11 2014 11 17
8. G. Doblhammer, A. Fink, and T. Fritze Short-term trends in dementia prevalence in Germany between the years 2007 and 2009 Alzheimer's Dement.: J. Alzheimer's Assoc. 11 2015 291 299
9. T.M. Hughes, L.H. Kuller, E.J. Barinas-Mitchell, E.M. McDade, W.E. Klunk, A.D. Cohen, C.A. Mathis, S.T. Dekosky, J.C. Price, and O.L. Lopez Arterial stiffness and beta-amyloid progression in nondemented elderly adults JAMA Neurol. 71 2014 562 568
10. C.R. Jack Jr., H.J. Wiste, S.D. Weigand, W.A. Rocca, D.S. Knopman, M.M. Mielke, V.J. Lowe, M.L. Senjem, J.L. Gunter, G.M. Preboske, V.S. Pankratz, P. Vemuri, and R.C. Petersen Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study Lancet Neurol. 13 2014 997 1005
11. B. Jones Dementia: reduction in the prevalence of dementia in the past 20 years Nat. Rev. Neurol. 9 2013 485
12. R.N. Kalaria, R. Akinyemi, and M. Ihara Does vascular pathology contribute to Alzheimer changes? J. Neurol. Sci. 322 2012 141 147
13. R.N. Kalaria, and M. Ihara Dementia: vascular and neurodegenerative pathways-will they meet? Nat. Rev. Neurol. 9 2013 487 488
14. S.P. Kennelly, B.A. Lawlor, and R.A. Kenny Blood pressure and the risk for dementia: a double edged sword Ageing Res. Rev. 8 2009 61 70
15. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study Br. Med. J. 322 2001 1447 1451
16. T. Ngandu, J. Lehtisalo, A. Solomon, E. Levalahti, S. Ahtiluoto, R. Antikainen, L. Backman, T. Hanninen, A. Jula, T. Laatikainen, J. Lindstrom, F. Mangialasche, T. Paajanen, S. Pajala, M. Peltonen, R. Rauramaa, A. Stigsdotter-Neely, T. Strandberg, J. Tuomilehto, H. Soininen, and M. Kivipelto A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial Lancet 2015
17. S. Norton, F.E. Matthews, D.E. Barnes, K. Yaffe, and C. Brayne Potential for primary prevention of Alzheimer's disease: an analysis of population-based data Lancet Neurol. 13 2014 788 794
18. A.M. Rawlings, A.R. Sharrett, A.L. Schneider, J. Coresh, M. Albert, D. Couper, M. Griswold, R.F. Gottesman, L.E. Wagenknecht, B.G. Windham, and E. Selvin Diabetes in midlife and cognitive change over 20 years: a cohort study Ann. Intern. Med. 161 2014 785 793
19. R.O. Roberts, D.S. Knopman, R.H. Cha, M.M. Mielke, V.S. Pankratz, B.F. Boeve, K. Kantarci, Y.E. Geda, C.R. Jack Jr., R.C. Petersen, and V.J. Lowe Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 55 2014 759 764
20. K.M. Rodrigue, J.R. Rieck, K.M. Kennedy, M.D. Devous Sr., R. Diaz-Arrastia, and D.C. Park Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects JAMA Neurol. 70 2013 600 606
21. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson, G. Persson, A. Oden, and A. Svanborg 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141 1145
22. P.D. Sloane, S. Zimmerman, C. Suchindran, P. Reed, L. Wang, M. Boustani, and S. Sudha The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances Annu. Rev. Public Health 23 2002 213 231
23. R.E. Tanzi A brief history of Alzheimer's disease gene discovery J. Alzheimer's Dis.: JAD 33 Suppl. 1 2013 S5 S13
24. R.E. Tanzi, D.M. Kovacs, T.W. Kim, R.D. Moir, S.Y. Guenette, and W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
25. M. Thambisetty, E. Jeffrey Metter, A. Yang, H. Dolan, C. Marano, A.B. Zonderman, J.C. Troncoso, Y. Zhou, D.F. Wong, L. Ferrucci, J. Egan, S.M. Resnick, and R.J. O'Brien Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging JAMA Neurol. 70 2013 1167 1172
26. A.H. van Beek, J.A. Claassen, M.G. Rikkert, and R.W. Jansen Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 28 2008 1071 1085
27. M. Wiesmann, A.J. Kiliaan, and J.A. Claassen Vascular aspects of cognitive impairment and dementia J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 33 2013 1696 1706
28. M. Wirth, H. Oh, E.C. Mormino, C. Markley, S.M. Landau, and W.J. Jagust The effect of amyloid beta on cognitive decline is modulated by neural integrity in cognitively normal elderly Alzheimer's Dement.: J. Alzheimer's Assoc. 9 2013 687 698.e1